Differences in presentation, severity and management of DKA in type 1 and type 2 diabetes during the COVID-19 pandemic.

COVID-19 infection in people with diabetes is associated with a disproportionately increased risk of complications and mortality.[1][1] Diabetic ketoacidosis (DKA) is an acute complication of diabetes.[2,3][2] Little is known about DKA in the presence of COVID-19 infection. This study aimed to